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A 75-year-old man presented with acute coronary syndrome; he had a saphenous vein graft thrombosis. Percutaneous
coronary intervention of bypass graft vessels is more challenging due to a higher incidence of periprocedural distal
micro-emobilization and myocardial infarction. Current guidelines for percutaneous coronary intervention advocate
the use of distal embolic protection devices, especially in patients with large thrombus burden, undergoing
percutaneous intervention for vein graft disease. This patient was treated by manual aspiration of graft thrombus using
a microvena catheter and successful clot removal was achieved. There are yet no best available therapeutic options for
patients undergoing percutaneous coronary intervention of saphenous vein graft lesions.
 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.
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Saphenous venous grafts develop intimalhyperplasia, subsequent atherosclerotic
degeneration and superimposed thrombus. This
can lead to the clinical scenario of stable angina
or acute coronary syndrome.
Given the risk of redo surgery, percutaneous
treatment is generally preferred and accounts for
10–15% in most centers [1].
These interventions present unique challenges
based on the soft and friable nature of the degen-
erated vein graft lesion, with increased tendency
for distal embolization to produce no-reflow and
myocardial infarction (MI).
Therefore, multiple device development strate-
gies have been achieved and both aspiration and1016–7315  2011 King Saud University.
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treating such lesions [2]. In this patient we used
a microvena catheter for thrombus aspiration
which was safe and non-traumatic.Case report
A 75-year-old male patient known to have diabe-
tes mellitus, hypertension, dyslipidemia and coro-
nary artery disease underwent coronary artery
bypass graft (SVG) surgery in 2004, left internal
mammary artery to left anterior descending artery,
saphenous vein graft to right coronary artery and a
jump (Y) graft to obtuse marginal 1 and obtuse
marginal 2. He presented to the emergency depart-
ment, complaining of chest pain and shortness of
Figure 1. SVG to OM1 showed a filling defect (thrombus) in the
proximal segment.
Figure 2. SVG to OM1 become clearer after clot suction.
Figure 3. There are both organized clots and fresh ones seen after
suction.
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care unit with acute coronary syndrome, non-ST
elevation MI and was started on ACS medication.
An ECG showed lateral ST-T wave changes and
his troponin I was positive 1.8 ng/ml, the echocar-
diogram showed moderate hypokinesis of poster-
lateral wall and the ejection fraction was 50%.
On the second day the patient underwent a cor-
onary angiogram, which showed a patent saphe-
nous graft to right coronary artery, patent leftinternal mammary artery to left anterior descend-
ing artery and patent Y – graft to obtuse marginal
2 and thrombus in the saphenous graft to obtuse
marginal 1 (Fig. 1).
Percutaneous intervention was done using a
manual suction technique with a small pediatric
microvena snare catheter 4 french (ev3, Plymouth,
Minnesota, USA). After a few attempts of manual
suction the graft became patent (Fig. 2) and both
small, organized and fresh clots were removed
(Fig. 3). No angioplasty was done in this case
and the patient was discharged from the hospital
in very stable condition within a few days.Discussion
Intervention has become an attractive alterna-
tive to re-operation in patients with SVG, but is
also associated with less favorable acute and
long-term outcomes compared with percutaneous
coronary intervention (PCI) of native vessels due
to a higher incidence of periprocedural micro-
embolization and late restenosis.
In patients with a SVG as the culprit vessel in
acute MI, the mortality within one year is 20%.
However, recent studies indicate that vein graft
MI carries a greater risk of mortality than those
involving native coronary arteries, and that previ-
ous CABG surgery is an independent predictor of
mortality [3].
The angiography results will determine the
method of percutaneous coronary intervention. If
a thrombus in the culprit artery or venous graft
is detected then such lesions can be treated by
aspiration or suction methods using an aspiration
or thrombectomy device, which are available in
well-known markets such as Export and Diver
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vices were used, or recommended to be used, in
large vessels with a large clot burden. The role
of protection devices which reduce distal remobi-
lization and no-reflow phenomenon have been
well established and now are represented as a
‘must’ for almost all of the PCI in SVG procedures,
manual suction using the same guiding catheter
with deep engagement was used in some cases,
mechanical thrombectomy devices like Angiojet
or X-sizer are still in practice and in use by some
cath labs [5], in some cases of big clots, invasive
cardiologists prefer to use all methods together
to minimize the distal embolization and decrease
the no reflow phenomenon.
Other methods like conventional balloon angio-
plasty or using stents either BMS or DES. Some
cases may be treated with covered stents [6].
In this case, patient was treated in the usual
manner with anti-ischemic medication, and per-
cutaneous graft intervention using microvena
snare catheter, which is mainly used in pediatric
cath labs for different purposes. It comes as a
snare kit including a snare and a catheter. For this
case, only the catheter itself was used. It has been
used before in the same cath lab for three different
adult cases with clots in native coronary arteries
and it had been found that it is one of the least
traumatic devices in such a case. Manual suction
was applied through this catheter in a repeated
manner. Following the manual suction, angio-
graphic pictures showed a clear SVG. From this
limited experience with microvena catheter, the
results have been very good. The optimal strategy
for treating these SVG lesions as yet remains
unclear.Conclusion
Saphenous graft thrombosis is a challenging
pathology. It can be removed by available aspira-
tion catheters using a small and less traumatic
catheter such as the pediatric microvena snare
catheter. In this patient the treatment was feasible
and safe.Conflict of interest statement
The authors have no conflicts of interest to
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